EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics of intra‐articular buprenorphine in horses with lipopolysaccharide‐induced synovitis

Gabriel Castro-Cuellar, Jeannette Cremer iD, Patricia Queiroz-Williams, Heather K Knych iD, Britta S Leise

Journal of Veterinary Pharmacology and Therapeutics · 2023

DOI: 10.1111/jvp.13119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2023. Verfasst von Gabriel Castro-Cuellar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA. Hauptthemen laut MEDLINE: Buprenorphine, Horse Diseases, Synovitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Charles Cusimano EHSP grant, Louisiana State University School of Veterinary Medicine Charles V. Cusimano EHSV funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this study was to describe the pharmacokinetics of intra‐articular (IA) administered buprenorphine in horses with lipopolysaccharide (LPS)‐induced synovitis. Radiocarpal synovitis was induced in six healthy adult horses with the IA injection of LPS (0.5 ng/joint) on two occasions in a randomized cross‐over design. Treatments (IA buprenorphine (IAB) at 5 μg/kg plus intravenous saline; and intravenous buprenorphine (IVB) at 5 μg/kg plus IA saline) were administered 4 h following LPS injection. Concentrations of buprenorphine were assessed in plasma and synovial fluid (SF) at 0.5, 2, 6, 12, and 24 h after administration. Pharmacokinetic parameters after IVB and IAB in plasma and synovial fluid were calculated using a nonlinear mixed effects model. IAB was detectable in SF of all horses at 24 h [median concentration of 6.2 (3.46–22.6) ng/mL]. IAB resulted in a median plasma concentration of 0.59 (0.42–1.68) ng/mL at 0.5 h and was detectable in all subjects for up to 6 h and in two horses for up to 12 h. IVB resulted in SF concentrations detected up to 6 h in all horses [median concentration of 0.12 (0.07–0.82) ng/mL]. Results suggest that IA buprenorphine remains present in the inflamed joint for at least 24 h and systemic absorption occurs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BuprenorphineHorse DiseasesSynovitisAnimalsHorsesInjections, Intra-ArticularLipopolysaccharidesSynovial Fluid

Stichwörter der Autor:innen

buprenorphinehorseintra-articularlipopolysaccharidepharmacokineticssynovitis

Substanzen

BuprenorphineLipopolysaccharides

Autor:innen und Institutionen

  • Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA.
  • KL Maddy Equine Analytical Pharmacology Lab, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.

ORCID-Profile: Jeannette Cremer, Heather K Knych

Förderung

  • Charles Cusimano EHSP grant
  • Louisiana State University School of Veterinary Medicine Charles V. Cusimano EHSV funding

Zitieren

APA

Castro-Cuellar, G., Cremer, J., Queiroz-Williams, P., Knych, H. K., & Leise, B. S. (2023). Pharmacokinetics of intra‐articular buprenorphine in horses with lipopolysaccharide‐induced synovitis. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.13119

Vancouver

Castro-Cuellar G, Cremer J, Queiroz-Williams P, Knych HK, Leise BS. Pharmacokinetics of intra‐articular buprenorphine in horses with lipopolysaccharide‐induced synovitis. Journal of Veterinary Pharmacology and Therapeutics. 2023. doi:10.1111/jvp.13119

BibTeX
@article{CastroCuellar2023,
  author = {Castro-Cuellar, Gabriel and Cremer, Jeannette and Queiroz-Williams, Patricia and Knych, Heather K and Leise, Britta S},
  title = {Pharmacokinetics of intra‐articular buprenorphine in horses with lipopolysaccharide‐induced synovitis},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2023},
  doi = {10.1111/jvp.13119}
}
Kostenlos starten →